Cowden syndrome (CS) is a genetic disorder characterized by multiple benign tissue growths (i.e., hamartomas) and an increased risk of developing specific cancers, such as breast, thyroid, kidney, endometrial, or colorectal cancer (Genetics Home Reference, 2012). This genetic syndrome was named after a person diagnosed with the disorder (Lloyd & Dennis, 1963). CS is part of a larger syndrome called PTEN hamartomatous syndrome, which also includes Bannayan-Riley-Ruvalcaba syndrome, PTEN-related Proteus syndrome, and Proteus-like syndrome (Eng, 2014).
Bushby, K. M., Cole, T., Matthews, J. N., & Goodship, J. A. (1992). Centiles for adult head circumference. Archives of Disease in Childhood, 67, 1286-1287.
Eng, C. (2014). PTEN hamartoma tumor syndrome (PHTS). In R. A. Pagon, M. P. Adam, H. H. Ardiner, T. D. Bird, C. R. Dolan, C. T. Fong, … K. Stephens (Eds.), GeneReviews®. Retrieved from http://www.ncbi.nlm.nih.gov/books/NBK1488
Lloyd, K. M., II, & Dennis, M. (1963). Cowden's disease. A possible new symptom complex with multiple system involvement. Annals of Internal Medicine, 58, 136-142.
Mester, J. L., Tilot, A. K., Rybicki, L. A., Frazier, T. W., II, & Eng, C. (2011). Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in PTEN knock-in murine model. European Journal of Human Genetics, 19, 763-768.
Ngeow, J., Stanuch, K., Mester, J. L., Barnholtz-Sloan, J. S., & Eng, C. (2014). Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations. Journal of Clinical Oncology, 32, 1818-1824. doi:10.1200/jco.2013.53.6656
Pilarski, R., Burt, R., Kohlman, W., Pho, L., Shannon, K. M., & Swisher, E. (2013). Cowden syndrome and the PTEN hamartoma tumor syndrome: Systematic review and revised diagnostic criteria. Journal of the National Cancer Institute, 105, 1607-1616.
Stuppia, L., Antonucci, I., Palka, G., & Gatta, V. (2012). Use of the MLPA assay in the molecular diagnosis of gene copy number alterations in human genetic diseases. International Journal of Molecular Sciences, 13, 3245-3276. doi:10.3390/ijms13033245
Tan, M. H., Mester, J. L., Ngeow, J., Rybicki, L. A., Orloff, M. S., & Eng, C. (2012). Lifetime cancer risks in individuals with germline PTEN mutations. Clinical Cancer Research, 18, 400-407.